An estimated 3 million Americans have an inflammatory bowel disease (IBD) such as Crohn's disease or ulcerative colitis. But ...
Small molecule drugs dominate new drug approvals and are crucial for treating diverse diseases. They are typically low-weight, providing easy absorption and versatile delivery methods. Their simpler ...
As biological data volume continues to grow, sequence-based AI is poised to become the dominant discovery layer across pharma ...
The new molecules selectively reduced inflammatory signaling in human immune cells without affecting other immune pathways. Treatment with the molecules also reduced inflammation in mice with the ...
WASHINGTON, Aug. 18, 2025 — Acetaminophen is one of the most common painkillers and is found in hundreds of different medications. While safe at recommended doses, acetaminophen overdose is the ...
-- Gilead and Terray Will Leverage Terray’s tNova Drug Discovery Platform to Identify Small Molecule Therapeutics Against Targets of Interest -- -- Gilead Has Exclusive Option to Develop and ...
Vancouver, British Columbia--(Newsfile Corp. - January 22, 2025) - InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a pharmaceutical company focused on developing a pipeline of ...
The Global Small Molecule Innovator CDMO Market offers opportunities in outsourcing due to growing structural drug complexity ...
Jia’s team developed a protocol to improve the screening of protein pockets. This involved identifying the pockets, removing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results